Progesterone receptor and human epidermal growth factor receptor 2 status: An independent influence on the efficacy of endocrine therapy in breast cancer? Reply

被引：1
|
作者：
Dowsett, M [1 ]
Cuzick, J
Wale, C
Howell, T
Houghton, J
Baum, M
Buzdar, A
机构：
[1] Royal Marsden NHS Fdn Trust, London, England
[2] Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London, England
[3] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England
[4] UCL Hosp NHS Trust, London, England
[5] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 09期
关键词：
D O I：
10.1200/JCO.2005.05.1623
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1482 / 1482
页数：1
相关论文
共 50 条
  • [41] Oestrogen receptor/progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer: a 9-year study at Princess Noorah Oncology Center, Saudi Arabia
    Satti, Mohamed B.
    HISTOPATHOLOGY, 2011, 59 (03) : 537 - 542
  • [42] EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN BREAST-CANCER - ASSOCIATION WITH RESPONSE TO ENDOCRINE THERAPY
    NICHOLSON, RI
    MCCLELLAND, RA
    GEE, JMW
    MANNING, DL
    CANNON, P
    ROBERTSON, JFR
    ELLIS, IO
    BLAMEY, RW
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 29 (01) : 117 - 125
  • [43] Clinical efforts to combine endocrine agents with targeted therapies against epidermal growth factor receptor/human epidermal growth factor receptor 2 and mammalian target of rapamycin in breast cancer
    Johnston, SRD
    CLINICAL CANCER RESEARCH, 2006, 12 (03) : 1061S - 1068S
  • [44] Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer
    Leonard, DS
    Hill, ADK
    Kelly, L
    Dijkstra, B
    McDermott, E
    O'Higgins, NJ
    BRITISH JOURNAL OF SURGERY, 2002, 89 (03) : 262 - 271
  • [45] Implications of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Wolff, Antonio C.
    Tung, Nadine M.
    Carey, Lisa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (25) : 2189 - +
  • [46] Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
    Gelmon, Karen A.
    Cristofanilli, Massimo
    Rugo, Hope S.
    DeMichele, Angela M.
    Joy, Anil A.
    Castrellon, Aurelio
    Sleckman, Bethany
    Mori, Ave
    Theall, Kathy Puyana
    Lu, Dongrui R.
    Huang, Xin
    Bananis, Eustratios
    Finn, Richard S.
    Slamon, Dennis J.
    BREAST JOURNAL, 2020, 26 (03): : 368 - 375
  • [47] The Epidermal Growth Factor Receptor in Breast Cancer
    Stephen B. Fox
    Adrian L. Harris
    Journal of Mammary Gland Biology and Neoplasia, 1997, 2 : 131 - 141
  • [48] The Epidermal Growth Factor Receptor in Breast Cancer
    Fox, Stephen B.
    Harris, Adrian L.
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1997, 2 (02) : 131 - 141
  • [49] Re: Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent human epidermal growth factor receptor-targeted therapy - Responses
    Veronesi, Umberto
    Bonanni, Bernardo
    Decensi, Andrea
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (21) : 1644 - 1645
  • [50] Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in invasive breast cancer in women
    Badowska-Kozakiewicz, Anna M.
    Sobol, Maria
    Patera, Janusz
    Kozlowski, Wojciech
    ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (03) : 466 - 471
12345